A business in context
ATRC research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-09-23 | Privitera Salvatore | S · Sale | Common Stock | 4519.0 | 60.0 |
| 2026-09-11 | GROVES REGINA E | S · Sale | Common Stock | 5313.0 | 54.22 |
| 2026-09-08 | Privitera Salvatore | S · Sale | Common Stock | 3657.0 | 55.0 |
| 2026-09-02 | Privitera Salvatore | S · Sale | Common Stock | 7763.0 | 52.5 |
| 2026-08-24 | Dahlquist Karl S. | S · Sale | Common Stock | 9370.0 | 48.89 |
| 2026-08-05 | Yuen Maggie | S · Sale | Common Stock | 3500.0 | 38.42 |
| 2026-08-05 | Prange Karen | S · Sale | Common Stock | 3564.0 | 38.8 |
| 2026-07-30 | CARREL MICHAEL H | G · Gift | Common Stock | 4000.0 | 0.0 |
| 2026-07-30 | CARREL MICHAEL H | G · Gift | Common Stock | 700.0 | 0.0 |
| 2026-07-29 | Noznesky Justin J | S · Sale | Common Stock | 6182.0 | 38.8 |
| 2026-07-28 | Doraiswamy Vinayak | S · Sale | Common Stock | 6000.0 | 38.88 |
| 2026-07-28 | WEHRWEIN SVEN | M · Exercise / conversion | Common Stock | 25000.0 | 19.95 |
| 2026-07-28 | WEHRWEIN SVEN | S · Sale | Common Stock | 25000.0 | 37.84 |
| 2026-07-28 | WEHRWEIN SVEN | M · Exercise / conversion | Non-qualified Stock Option (right to buy) | 25000.0 | 0.0 |
| 2026-06-30 | Doraiswamy Vinayak | A · Grant / award | Common Stock | 636.0 | 23.78 |
| 2026-06-30 | Dahlquist Karl S. | A · Grant / award | Common Stock | 636.0 | 23.78 |
| 2026-06-30 | Seith Douglas J | A · Grant / award | Common Stock | 527.0 | 23.78 |
| 2026-06-30 | Privitera Salvatore | A · Grant / award | Common Stock | 636.0 | 23.78 |
| 2026-06-30 | CARREL MICHAEL H | A · Grant / award | Common Stock | 636.0 | 23.78 |
Identity & relationships
SEC issuer · 0001323885AtriCure, Inc.
Search names and former names
View Wikidata identity and references ↗
- AtriCure (United States) · alias · wikidata
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $465.31M | $499.78M |
| 2023-12-31 | $399.25M | $441.46M |
| 2022-12-31 | $330.38M | $380.31M |
| 2021-12-31 | $274.33M | $341.06M |
| 2020-12-31 | $206.53M | $268.88M |
| 2019-12-31 | $230.81M | $304.17M |
| 2018-12-31 | $201.63M | $270.54M |
| 2017-12-31 | $174.72M | $240.16M |